These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 1353953)
1. Clinical and laboratory correlates of human immunodeficiency virus infection in a cohort of intravenous drug users from New York, NY. el-Sadr W; Goetz RR; Sorrell S; Joseph M; Ehrhardt A; Gorman JM Arch Intern Med; 1992 Aug; 152(8):1653-9. PubMed ID: 1353953 [TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men. Palenicek J; Nelson KE; Vlahov D; Galai N; Cohn S; Saah AJ Arch Intern Med; 1993 Aug; 153(15):1806-12. PubMed ID: 8101438 [TBL] [Abstract][Full Text] [Related]
3. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411 [TBL] [Abstract][Full Text] [Related]
4. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100 [TBL] [Abstract][Full Text] [Related]
5. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users. Margolick JB; Muñoz A; Vlahov D; Astemborski J; Solomon L; He XY; Nelson KE; Saah AJ Arch Intern Med; 1994 Apr; 154(8):869-75. PubMed ID: 7908795 [TBL] [Abstract][Full Text] [Related]
6. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City. Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London. Mohsen AH; Murad S; Easterbrook PJ HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288 [TBL] [Abstract][Full Text] [Related]
8. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Nelson KE; Vlahov D; Solomon L; Cohn S; Muñoz A Arch Intern Med; 1995 Jun; 155(12):1305-11. PubMed ID: 7778962 [TBL] [Abstract][Full Text] [Related]
9. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Hartel DM; Schoenbaum EE Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816 [TBL] [Abstract][Full Text] [Related]
10. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II. AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101 [TBL] [Abstract][Full Text] [Related]
11. Clinical features of HIV infection in drug users of Manipur. Panda S; Kamei G; Pamei M; Sarkar S; Sarkar K; Singh ND; Deb BC Natl Med J India; 1994; 7(6):267-9. PubMed ID: 7841877 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study. Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423 [TBL] [Abstract][Full Text] [Related]
13. HIV antibodies among intravenous drug users in Bahrain. al-Haddad MK; Khashaba AS; Baig BZ; Khalfan S J Commun Dis; 1994 Sep; 26(3):127-32. PubMed ID: 7868834 [TBL] [Abstract][Full Text] [Related]
14. Assessment of nutritional, clinical, and immunologic status of HIV-infected, inner-city patients with multiple risk factors. Luder E; Godfrey E; Godbold J; Simpson DM J Am Diet Assoc; 1995 Jun; 95(6):655-60. PubMed ID: 7759740 [TBL] [Abstract][Full Text] [Related]
15. Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City. Absalon J; Fuller CM; Ompad DC; Blaney S; Koblin B; Galea S; Vlahov D AIDS Behav; 2006 Nov; 10(6):707-15. PubMed ID: 16676223 [TBL] [Abstract][Full Text] [Related]
16. Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study. Vanhems P; Lambert J; Guerra M; Hirschel B; Allard R J Infect Dis; 1999 Dec; 180(6):1803-8. PubMed ID: 10558934 [TBL] [Abstract][Full Text] [Related]
17. Sexually transmitted diseases in 1161 HIV-positive patients: a 38-month prospective study in southern Spain. Muñoz-Pérez MA; Rodriguez-Pichardo A; Camacho Martinez F J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):221-6. PubMed ID: 9883433 [TBL] [Abstract][Full Text] [Related]
18. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients]. Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503 [TBL] [Abstract][Full Text] [Related]
19. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna. Armbruster C; Kriwanek S; Vorbach H Wien Klin Wochenschr; 2000 Sep; 112(17):754-60. PubMed ID: 11042904 [TBL] [Abstract][Full Text] [Related]
20. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]